PFBT
ALT icon

Parkside Financial Bank & Trust’s Altimmune ALT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-105
Closed -$407 – 2716
2025
Q2 		$407 Buy
+105
New +$568 ﹤0.01% 2618

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkside Financial Bank & Trust's ALT Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of Altimmune (ALT) in Q3 2025, closing a stake of 105 shares — an estimated $407 sold.

Parkside Financial Bank & Trust first reported a position in ALT in Q2 2025 and held it in 1 quarter. The position peaked at $407 in Q2 2025. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Parkside Financial Bank & Trust reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 105 Altimmune shares in Q3 2025, an estimated $407.
  • Parkside Financial Bank & Trust first reported a position in Altimmune in Q2 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Altimmune position peaked at $407 in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.